Using Electronic Medical Record Data to Characterize the Level of Medication Use by Age-Groups in a Network of Primary Care Clinics

被引:7
作者
Freund, Jeff [1 ]
Meiman, Jon [2 ]
Kraus, Connie [3 ,4 ]
机构
[1] Univ Colorado, Skaggs Sch Pharm & Phamaceut Sci, Aurora, CO USA
[2] Univ Wisconsin, Dept Family Med, Madison, WI USA
[3] Univ Wisconsin, Sch Pharm, CHS, Madison, WI 53706 USA
[4] Univ Wisconsin, Sch Pharm, Off Global Hlth, Madison, WI 53706 USA
关键词
polypharmacy; primary care; family medicine; medication use; sociodemographic characteristics;
D O I
10.1177/2150131913495243
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: Our primary aim was to characterize the level of medication use across age-groups by examining electronic medical record data for a large number of patients receiving care in primary care clinics. A secondary aim was to identify factors associated with higher levels of medication use or polypharmacy. Methods: We conducted a retrospective query of electronic medical record data from a clinical data warehouse, evaluating 114 012 patients seen in primary care clinics at least once in the previous 6 months. Medication use was evaluated in 3 different categories: level 1 (0-4 medications), level 2 (5-9 medications), and level 3 (>= 10 medications). Multivariate analysis was used to analyze different patient demographics and comorbidities for association with level of medication use. Results: At ages 18 to 24 years, 15% (male) to 23% (female) of patients were taking greater than 5 medications, a trend that continued to increase with older cohorts. Female patients were more likely to have level 2 (odds ratio [OR] = 1.76) and level 3 (OR = 2.73) use compared with men. Level 2 and level 3 use was associated with other patient characteristics, including number of patient encounters (level 2 OR = 2.99; level 3 OR = 8.08 for >7 encounters) and common chronic conditions such as chronic pain (level 2 OR = 2.56; level 3 OR = 6.40), diabetes (level 2 OR = 2.4; level 3 OR = 4.61), heart disease (level 2 OR = 1.99; level 3 OR = 3.65), hypertension (level 2 OR = 2.27; level 3 OR = 2.87), and dyslipidemia (level 2 OR = 1.82; level 3 OR = 2.12). Conclusion: Electronic medical record data may be an important tool for providing more comprehensive information regarding medication usage. Medication usage assessed by electronic medical records, even among the youngest cohort, appears to be greater than other sources of medication usage indicate. Higher levels of medication use were associated with a number of factors, including gender, body mass index, number of patient encounters, and comorbid conditions.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 28 条
[1]   Determinants of medicine use in a Swedish primary health care practice population [J].
Al-Windi, A .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (01) :47-51
[2]  
[Anonymous], 2011, PRESCR DRUG US 30 DA
[3]   Polypharmacy: Correlations with sex, age and drug regimen - A prescription database study [J].
Bjerrum, L ;
Sogaard, J ;
Hallas, J ;
Kragstrup, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :197-202
[4]  
Cipolle R.J., 2004, PHARMACEUTICAL CARE, V2nd
[5]  
Corsonello Andrea, 2007, Ther Clin Risk Manag, V3, P197, DOI 10.2147/tcrm.2007.3.1.197
[6]   A Pharmacoepidemiologic Study of Community-Dwelling, Disabled Older Women: Factors Associated With Medication Use [J].
Crentsil, Victor ;
Ricks, Michelle O. ;
Xue, Qian-Li ;
Fried, Linda P. .
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2010, 8 (03) :215-224
[7]  
F Linda, 2007, Pharm Pract (Granada), V5, P85
[8]  
Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x
[9]  
Garcia RM, 2006, J FAM PRACTICE, V55, P305
[10]   Benefits and harms of direct to consumer advertising: a systematic review [J].
Gilbody, S ;
Wilson, P ;
Watt, I .
QUALITY & SAFETY IN HEALTH CARE, 2005, 14 (04) :246-250